807 related articles for article (PubMed ID: 27851748)
1. Chromosomal Instability Estimation Based on Next Generation Sequencing and Single Cell Genome Wide Copy Number Variation Analysis.
Greene SB; Dago AE; Leitz LJ; Wang Y; Lee J; Werner SL; Gendreau S; Patel P; Jia S; Zhang L; Tucker EK; Malchiodi M; Graf RP; Dittamore R; Marrinucci D; Landers M
PLoS One; 2016; 11(11):e0165089. PubMed ID: 27851748
[TBL] [Abstract][Full Text] [Related]
2. Analysis of BRCA2 Copy Number Loss and Genomic Instability in Circulating Tumor Cells from Patients with Metastatic Castration-resistant Prostate Cancer.
Barnett ES; Schultz N; Stopsack KH; Lam ET; Arfe A; Lee J; Zhao JL; Schonhoft JD; Carbone EA; Keegan NM; Wibmer A; Wang Y; Solit DB; Abida W; Wenstrup R; Scher HI
Eur Urol; 2023 Feb; 83(2):112-120. PubMed ID: 36123219
[TBL] [Abstract][Full Text] [Related]
3. Morphology-Predicted Large-Scale Transition Number in Circulating Tumor Cells Identifies a Chromosomal Instability Biomarker Associated with Poor Outcome in Castration-Resistant Prostate Cancer.
Schonhoft JD; Zhao JL; Jendrisak A; Carbone EA; Barnett ES; Hullings MA; Gill A; Sutton R; Lee J; Dago AE; Landers M; Bakhoum SF; Wang Y; Gonen M; Dittamore R; Scher HI
Cancer Res; 2020 Nov; 80(22):4892-4903. PubMed ID: 32816908
[TBL] [Abstract][Full Text] [Related]
4. A streamlined workflow for single-cells genome-wide copy-number profiling by low-pass sequencing of LM-PCR whole-genome amplification products.
Ferrarini A; Forcato C; Buson G; Tononi P; Del Monaco V; Terracciano M; Bolognesi C; Fontana F; Medoro G; Neves R; Möhlendick B; Rihawi K; Ardizzoni A; Sumanasuriya S; Flohr P; Lambros M; de Bono J; Stoecklein NH; Manaresi N
PLoS One; 2018; 13(3):e0193689. PubMed ID: 29494651
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic diversity of circulating tumour cells in patients with metastatic castration-resistant prostate cancer.
McDaniel AS; Ferraldeschi R; Krupa R; Landers M; Graf R; Louw J; Jendrisak A; Bales N; Marrinucci D; Zafeiriou Z; Flohr P; Sideris S; Crespo M; Figueiredo I; Mateo J; de Bono JS; Dittamore R; Tomlins SA; Attard G
BJU Int; 2017 Nov; 120(5B):E30-E44. PubMed ID: 27539393
[TBL] [Abstract][Full Text] [Related]
6. Single-Cell Circulating Tumor Cell Analysis Reveals Genomic Instability as a Distinctive Feature of Aggressive Prostate Cancer.
Malihi PD; Graf RP; Rodriguez A; Ramesh N; Lee J; Sutton R; Jiles R; Ruiz Velasco C; Sei E; Kolatkar A; Logothetis C; Navin NE; Corn P; Aparicio AM; Dittamore R; Hicks J; Kuhn P; Zurita AJ
Clin Cancer Res; 2020 Aug; 26(15):4143-4153. PubMed ID: 32341031
[TBL] [Abstract][Full Text] [Related]
7. Androgen receptor expression on circulating tumor cells in metastatic breast cancer.
Fujii T; Reuben JM; Huo L; Espinosa Fernandez JR; Gong Y; Krupa R; Suraneni MV; Graf RP; Lee J; Greene S; Rodriguez A; Dugan L; Louw J; Lim B; Barcenas CH; Marx AN; Tripathy D; Wang Y; Landers M; Dittamore R; Ueno NT
PLoS One; 2017; 12(9):e0185231. PubMed ID: 28957377
[TBL] [Abstract][Full Text] [Related]
8. Whole Genomic Copy Number Alterations in Circulating Tumor Cells from Men with Abiraterone or Enzalutamide-Resistant Metastatic Castration-Resistant Prostate Cancer.
Gupta S; Li J; Kemeny G; Bitting RL; Beaver J; Somarelli JA; Ware KE; Gregory S; Armstrong AJ
Clin Cancer Res; 2017 Mar; 23(5):1346-1357. PubMed ID: 27601596
[No Abstract] [Full Text] [Related]
9. Tumor Evolution and Therapeutic Choice Seen through a Prism of Circulating Tumor Cell Genomic Instability.
Tayoun T; Oulhen M; Aberlenc A; Farace F; Pawlikowska P
Cells; 2021 Feb; 10(2):. PubMed ID: 33562741
[TBL] [Abstract][Full Text] [Related]
10. Discordant and heterogeneous clinically relevant genomic alterations in circulating tumor cells vs plasma DNA from men with metastatic castration resistant prostate cancer.
Gupta S; Hovelson DH; Kemeny G; Halabi S; Foo WC; Anand M; Somarelli JA; Tomlins SA; Antonarakis ES; Luo J; Dittamore RV; George DJ; Rothwell C; Nanus DM; Armstrong AJ; Gregory SG
Genes Chromosomes Cancer; 2020 Apr; 59(4):225-239. PubMed ID: 31705765
[TBL] [Abstract][Full Text] [Related]
11. Isolation and genomic analysis of circulating tumor cells from castration resistant metastatic prostate cancer.
Magbanua MJ; Sosa EV; Scott JH; Simko J; Collins C; Pinkel D; Ryan CJ; Park JW
BMC Cancer; 2012 Feb; 12():78. PubMed ID: 22373240
[TBL] [Abstract][Full Text] [Related]
12. Genomic Analysis of Localized High-Risk Prostate Cancer Circulating Tumor Cells at the Single-Cell Level.
Rangel-Pozzo A; Liu S; Wajnberg G; Wang X; Ouellette RJ; Hicks GG; Drachenberg D; Mai S
Cells; 2020 Aug; 9(8):. PubMed ID: 32784507
[TBL] [Abstract][Full Text] [Related]
13. Expanded Genomic Profiling of Circulating Tumor Cells in Metastatic Breast Cancer Patients to Assess Biomarker Status and Biology Over Time (CALGB 40502 and CALGB 40503, Alliance).
Magbanua MJM; Rugo HS; Wolf DM; Hauranieh L; Roy R; Pendyala P; Sosa EV; Scott JH; Lee JS; Pitcher B; Hyslop T; Barry WT; Isakoff SJ; Dickler M; Van't Veer L; Park JW
Clin Cancer Res; 2018 Mar; 24(6):1486-1499. PubMed ID: 29311117
[No Abstract] [Full Text] [Related]
14. Genomic Analysis of Circulating Tumor Cells at the Single-Cell Level.
Lu S; Chang CJ; Guan Y; Szafer-Glusman E; Punnoose E; Do A; Suttmann B; Gagnon R; Rodriguez A; Landers M; Spoerke J; Lackner MR; Xiao W; Wang Y
J Mol Diagn; 2020 Jun; 22(6):770-781. PubMed ID: 32247862
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive Mutation and Copy Number Profiling in Archived Circulating Breast Cancer Tumor Cells Documents Heterogeneous Resistance Mechanisms.
Paoletti C; Cani AK; Larios JM; Hovelson DH; Aung K; Darga EP; Cannell EM; Baratta PJ; Liu CJ; Chu D; Yazdani M; Blevins AR; Sero V; Tokudome N; Thomas DG; Gersch C; Schott AF; Wu YM; Lonigro R; Robinson DR; Chinnaiyan AM; Bischoff FZ; Johnson MD; Park BH; Hayes DF; Rae JM; Tomlins SA
Cancer Res; 2018 Feb; 78(4):1110-1122. PubMed ID: 29233927
[TBL] [Abstract][Full Text] [Related]
16. Mutational analysis of single circulating tumor cells by next generation sequencing in metastatic breast cancer.
De Luca F; Rotunno G; Salvianti F; Galardi F; Pestrin M; Gabellini S; Simi L; Mancini I; Vannucchi AM; Pazzagli M; Di Leo A; Pinzani P
Oncotarget; 2016 May; 7(18):26107-19. PubMed ID: 27034166
[TBL] [Abstract][Full Text] [Related]
17. Enrichment and mutation detection of circulating tumor cells from blood samples.
Kou R; Zhao J; Gogoi P; Carskadon S; Chow W; Hwang C; Palanisamy N; Leung C; Wang Y
Oncol Rep; 2018 Jun; 39(6):2537-2544. PubMed ID: 29620284
[TBL] [Abstract][Full Text] [Related]
18. Single-cell sequencing deciphers a convergent evolution of copy number alterations from primary to circulating tumor cells.
Gao Y; Ni X; Guo H; Su Z; Ba Y; Tong Z; Guo Z; Yao X; Chen X; Yin J; Yan Z; Guo L; Liu Y; Bai F; Xie XS; Zhang N
Genome Res; 2017 Aug; 27(8):1312-1322. PubMed ID: 28487279
[TBL] [Abstract][Full Text] [Related]
19. Rapid phenotypic and genomic change in response to therapeutic pressure in prostate cancer inferred by high content analysis of single circulating tumor cells.
Dago AE; Stepansky A; Carlsson A; Luttgen M; Kendall J; Baslan T; Kolatkar A; Wigler M; Bethel K; Gross ME; Hicks J; Kuhn P
PLoS One; 2014; 9(8):e101777. PubMed ID: 25084170
[TBL] [Abstract][Full Text] [Related]
20. Identification of genomic signatures in circulating tumor cells from breast cancer.
Kanwar N; Hu P; Bedard P; Clemons M; McCready D; Done SJ
Int J Cancer; 2015 Jul; 137(2):332-44. PubMed ID: 25529931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]